bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.03.10.710938

Cross-etiology transcriptomic conservation in hepatocellular carcinoma reveals opposing proliferation and hepatocyte-loss programs validated across cohorts

Romero, R.·Toledo, C.
View original source ↗Export metadata ↓

Abstract

BackgroundHepatocellular carcinoma (HCC) arises from diverse etiologies, but the extent to which viral etiologies converge on reproducible transcriptomic state axes remains incompletely resolved. MethodsWe analyzed HBV- and HCV-associated HCC discovery cohorts using Hallmark GSVA, limma-based differential modeling, and cross-cohort meta-analysis. Conserved tumor-upregulated and tumor-downregulated genes were distilled into ProlifHub and HepLoss modules, combined as HCCStateScore = ProlifHubScore - HepLossScore. Module performance was evaluated across multiple independent GEO cohorts, module-size robustness was tested across alternative top-N definitions, and TCGA-LIHC was used for continuous Cox survival modeling. An HBV-derived injury axis was constructed from an ordinal ALT/AST/HBV-DNA injury index in GSE83148 and tested in GSE121248 with adjustment for E2F/G2M activity and CIBERSORTx-inferred immune composition. ResultsHBV- and HCV-associated HCC showed conserved activation of proliferation/repair programs and suppression of hepatocyte functional programs. The HCCStateScore validated across independent HCC cohorts with consistently positive tumor-non-tumor deltas and high discrimination, and module-size sensitivity analysis showed that performance was not dependent on the top-20 cutoff. In TCGA-LIHC, higher ProlifHubScore and HCCStateScore were associated with poorer overall survival in continuous Cox models, including after age/sex/stage adjustment. A compact HBV injury program remained tumor-associated after simultaneous adjustment for E2F/G2M activity and CIBERSORTx-derived immune-composition covariates, with concordant results using an extended FDR-defined injury set. ConclusionsHCC exhibits a robust cross-etiology transcriptomic state characterized by opposing proliferation and hepatocyte-loss programs. The module framework provides a portable bulk transcriptomic state score and supports a residual tumor-associated HBV injury component that is not fully explained by proliferation or inferred immune composition.

Source connections

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Romero, R., Toledo, C.. 2026-03-13. Cross-etiology transcriptomic conservation in hepatocellular carcinoma reveals opposing proliferation and hepatocyte-loss programs validated across cohorts. https://doi.org/10.64898/2026.03.10.710938

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗
bioRxiv2026

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗
bioRxiv2026

CryoMV: Structure-Prior-Guided Modeling and Real-Particle Validation of Continuous Conformational Transitions in Cryo-EM

Continuous protein conformations are essential for understanding fundamental biological processes and supporting drug discovery. Although cryo-EM can resolve individual states at high resolution, recovering continuous heterogeneity from 2D particle images remains challenging. High noise, motion blur, and limited structural priors make it difficult to accurately generate and validate high-resolution continuous conformations using raw particle data. Here, we introduce cryoMV, a framework that integrates structure-prior-guided modeling with real-particle validation for continuous conformational transitions. CryoMV uses reference density maps to establish structural anchors and motion priors, models candidate transition paths between selected conformations, and transfers the learned representation to raw 2D cryo-EM particle images. Each candidate conformation is subsequently evaluated using the estimated particle poses and contrast transfer functions. Supported conformations are reconstructed through raw particle back-projection and assessed using canonical half-maps and Fourier shell correlation. On EMPIAR-10516 and EMPIAR-10345, cryoMV achieves excellent performance in terms of robustness, verifiability, and reconstruction resolution. By incorporating structure-prior modeling and evidence from the raw particles, cryoMV offers an explicit mechanism for assessing whether generated conformations are supported by experimental data and provides a practical approach to reducing model-induced artifacts in continuous cryo-EM heterogeneity analysis.

bioinformatics↗